CorMedix (CRMD) News Today $14.35 +0.21 (+1.49%) Closing price 04:00 PM EasternExtended Trading$14.32 -0.03 (-0.21%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CRMD Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period CorMedix Inc. to Present at Upcoming Investor Conferences in September 2025August 28 at 8:51 AM | quiverquant.comQCorMedix to Participate in Upcoming Investor ConferencesAugust 28 at 8:30 AM | globenewswire.comCorMedix: The Undervalued BreakthroughAugust 26 at 3:04 AM | seekingalpha.comCorMedix's (NASDAQ:CRMD) Earnings Aren't As Good As They AppearAugust 14, 2025 | finance.yahoo.comCorMedix Inc (NASDAQ:CRMD) Shares Bought by XTX Topco LtdAugust 14, 2025 | marketbeat.comCorMedix Shows Market Leadership With Jump To 92 RS RatingAugust 13, 2025 | msn.comCorMedix (NASDAQ:CRMD) Stock Price Up 8.9% - Should You Buy?August 13, 2025 | marketbeat.comCorMedix Completes $150M Convertible Notes OfferingAugust 12, 2025 | msn.comNeedham Maintains a Buy Rating on CorMedix (CRMD) With a $20 PTAugust 12, 2025 | msn.comCorMedix Inc. (NASDAQ:CRMD) Q2 2025 Earnings Call TranscriptAugust 12, 2025 | msn.comHC Wainwright Has Optimistic Outlook of CorMedix Q3 EarningsAugust 11, 2025 | marketbeat.comWall Street Zen Downgrades CorMedix (NASDAQ:CRMD) to BuyAugust 10, 2025 | marketbeat.comHC Wainwright Cuts CorMedix (NASDAQ:CRMD) Price Target to $17.00August 9, 2025 | marketbeat.comCorMedix, Inc. (CRMD) Q2 2025 Earnings Call TranscriptAugust 8, 2025 | seekingalpha.comCorMedix (NASDAQ:CRMD) Sees Unusually-High Trading Volume - Here's WhyAugust 8, 2025 | marketbeat.comCorMedix to Buy Melinta Therapeutics for $300 MillionAugust 7, 2025 | wsj.comMelinta Therapeutics Announces Strategic Acquisition by CorMedix, Underscoring Its Portfolio Value and Industry LeadershipAugust 7, 2025 | businesswire.comCormedix Inc. Reports Second Quarter 2025 Financial Results and Provides Business UpdateAugust 7, 2025 | globenewswire.comCorMedix to acquire Melinta Therapeutics, Creating Diversified Specialty Company With Strong Presence in Acute Care SettingsAugust 7, 2025 | globenewswire.comCorMedix (CRMD) Expected to Announce Earnings on WednesdayAugust 7, 2025 | marketbeat.comCorMedix Inc (NASDAQ:CRMD) Given Consensus Rating of "Moderate Buy" by AnalystsAugust 4, 2025 | marketbeat.comCorMedix Inc (NASDAQ:CRMD) Shares Bought by Private Advisor Group LLCJuly 31, 2025 | marketbeat.comCorMedix (NASDAQ:CRMD) Sees Strong Trading Volume - Here's WhyJuly 24, 2025 | marketbeat.comCan CorMedix (CRMD) Keep the Earnings Surprise Streak Alive?July 14, 2025 | msn.comCorMedix Inc. Advances Pediatric Dialysis Safety with New Clinical StudyJuly 11, 2025 | tipranks.comCorMedix Inc (NASDAQ:CRMD) Receives Average Rating of "Moderate Buy" from BrokeragesJuly 10, 2025 | marketbeat.comHC Wainwright Estimates CorMedix FY2027 EarningsJuly 2, 2025 | marketbeat.comWhat is HC Wainwright's Forecast for CorMedix Q2 Earnings?July 1, 2025 | marketbeat.comCorMedix (NASDAQ:CRMD) Rating Lowered to "Hold" at D Boral CapitalJuly 1, 2025 | marketbeat.comD. Boral Capital Downgrades CorMedix (CRMD)July 1, 2025 | msn.comHC Wainwright & Co. Initiates Coverage of CorMedix (CRMD) with Buy RecommendationJune 30, 2025 | msn.comCorMedix Seems Significantly UndervaluedJune 30, 2025 | seekingalpha.comCorMedix Analyst Says Investors Could Be Further RewardedJune 30, 2025 | benzinga.comD. Boral Capital Downgrades CorMedix (NASDAQ:CRMD) to HoldJune 30, 2025 | marketbeat.comCorMedix (NASDAQ:CRMD) Coverage Initiated by Analysts at HC WainwrightJune 30, 2025 | marketbeat.comCorMedix Shares Drop After $85 Million Public Offering PricesJune 27, 2025 | marketwatch.comUpgrade: Analysts Just Made A Captivating Increase To Their CorMedix Inc. (NASDAQ:CRMD) ForecastsJune 27, 2025 | finance.yahoo.comCorMedix (NASDAQ:CRMD) Shares Gap Down - Here's WhyJune 27, 2025 | marketbeat.comCorMedix Inc. Announces Pricing of Public Offering of Common StockJune 27, 2025 | gurufocus.comCorMedix Inc. Announces Pricing of Public Offering of Common Stock | CRMD Stock NewsJune 27, 2025 | gurufocus.comCorMedix Inc. Announces Pricing of Public Offering of Common StockJune 27, 2025 | globenewswire.comCorMedix stock falls after $85 million share offering announcementJune 27, 2025 | za.investing.comCorMedix Shares Drop 10% After Co. Announces Public Offering PlansJune 26, 2025 | marketwatch.comStrength Seen in CorMedix (CRMD): Can Its 21.7% Jump Turn into More Strength? - NasdaqJune 26, 2025 | nasdaq.comCorMedix Inc. Plans $85 Million Public Offering of Common StockJune 26, 2025 | quiverquant.comQCorMedix Inc. Announces Proposed Public Offering of Common StockJune 26, 2025 | globenewswire.comCorMedix Lifts Revenue Forecast On DefenCath Progress With A Large Dialysis Organization Customer - NasdaqJune 25, 2025 | nasdaq.comCormedix Analyst Ratings and Price Targets | NASDAQ:CRMD | BenzingaJune 25, 2025 | benzinga.comCorMedix announces customer implementationJune 24, 2025 | finance.yahoo.comCorMedix Inc. (CRMD): A Bull Case TheoryJune 24, 2025 | finance.yahoo.com Get CorMedix News Delivered to You Automatically Sign up to receive the latest news and ratings for CRMD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CRMD Media Mentions By Week CRMD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRMD News Sentiment▼1.471.03▲Average Medical News Sentiment CRMD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRMD Articles This Week▼44▲CRMD Articles Average Week Get the Latest News and Ratings for CRMD and Related Stocks Enter your email address to receive the latest news and analysts' ratings for CorMedix and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies ADMA News AAPG News PCVX News PTCT News LNTH News ACLX News ZLAB News AKRO News MIRM News MENS News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CRMD) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CorMedix Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share CorMedix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access